Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. - Filzmayer M; Petix M; Quarta L; Orlandi F; Goyal JA; Carmignani L; Briganti A; Micali S; Shariat SF; Wenzel M; Heß-Busch Y; Humke C; et al. (Annals of surgical oncology, 2026)